Corrections Noted in Table 2 of the Melanoma Self Surveillance Trial Article
-
May 1, 2026
May 1, 2026
Gene expression profiling sheds new light on malignant transformation in uveal melanoma
January 12, 2026
CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models
March 9, 2026